Search research articles
Contact Us
Filters
Showing results (91-100 of 99) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 99 results.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 15, 2019
Terminal Effector CD8 T Cells Defined by an IKZF2<sup>+</sup>IL-7R<sup>-</sup> Transcriptional Signature Express FcγRIIIA, Expand in HIV Infection, and Mediate Potent HIV-Specific Antibody-Dependent Cellular Cytotoxicity
Prossy Naluyima, Kerri G Lal, Margaret C Costanzo, et al.
The Lancet. HIV
|
February 10, 2020
Late boosting of the RV144 regimen with AIDSVAX B/E and ALVAC-HIV in HIV-uninfected Thai volunteers: a double-blind, randomised controlled trial
Punnee Pitisuttithum, Sorachai Nitayaphan, Suwat Chariyalertsak, et al.
Nature
|
July 16, 2011
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
Richard Possemato, Kevin M Marks, Yoav D Shaul, et al.
Cell Reports
|
January 21, 2014
ZFHX4 interacts with the NuRD core member CHD4 and regulates the glioblastoma tumor-initiating cell state
Yakov Chudnovsky, Dohoon Kim, Siyuan Zheng, et al.
Nature Medicine
|
April 3, 2020
Safety and immunogenicity of Ad26 and MVA vaccines in acutely treated HIV and effect on viral rebound after antiretroviral therapy interruption
Donn J Colby, Michal Sarnecki, Dan H Barouch, et al.
JCI Insight
|
May 8, 2023
ALVAC-HIV and AIDSVAX B/E vaccination induce improved immune responses compared with AIDSVAX B/E vaccination alone
Margaret C Costanzo, Dominic Paquin-Proulx, Alexandra Schuetz, et al.
Plos Pathogens
|
September 4, 2020
Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challenge
Kier Om, Dominic Paquin-Proulx, Maria Montero, et al.
Science Translational Medicine
|
April 2, 2025
Ebola virus vaccination elicits Ebola virus-specific immune responses without substantial cross-reactivity to other filoviruses
Thembi Mdluli, Suzanne Wollen-Roberts, Mélanie Merbah, et al.
Vaccines
|
May 28, 2022
A SARS-CoV-2 Spike Ferritin Nanoparticle Vaccine Is Protective and Promotes a Strong Immunological Response in the Cynomolgus Macaque Coronavirus Disease 2019 (COVID-19) Model
Sara C Johnston, Keersten M Ricks, Ines Lakhal-Naouar, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 99) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 99 results.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 15, 2019
Terminal Effector CD8 T Cells Defined by an IKZF2<sup>+</sup>IL-7R<sup>-</sup> Transcriptional Signature Express FcγRIIIA, Expand in HIV Infection, and Mediate Potent HIV-Specific Antibody-Dependent Cellular Cytotoxicity
Prossy Naluyima, Kerri G Lal, Margaret C Costanzo, et al.
The Lancet. HIV
|
February 10, 2020
Late boosting of the RV144 regimen with AIDSVAX B/E and ALVAC-HIV in HIV-uninfected Thai volunteers: a double-blind, randomised controlled trial
Punnee Pitisuttithum, Sorachai Nitayaphan, Suwat Chariyalertsak, et al.
Nature
|
July 16, 2011
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
Richard Possemato, Kevin M Marks, Yoav D Shaul, et al.
Cell Reports
|
January 21, 2014
ZFHX4 interacts with the NuRD core member CHD4 and regulates the glioblastoma tumor-initiating cell state
Yakov Chudnovsky, Dohoon Kim, Siyuan Zheng, et al.
Nature Medicine
|
April 3, 2020
Safety and immunogenicity of Ad26 and MVA vaccines in acutely treated HIV and effect on viral rebound after antiretroviral therapy interruption
Donn J Colby, Michal Sarnecki, Dan H Barouch, et al.
JCI Insight
|
May 8, 2023
ALVAC-HIV and AIDSVAX B/E vaccination induce improved immune responses compared with AIDSVAX B/E vaccination alone
Margaret C Costanzo, Dominic Paquin-Proulx, Alexandra Schuetz, et al.
Plos Pathogens
|
September 4, 2020
Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challenge
Kier Om, Dominic Paquin-Proulx, Maria Montero, et al.
Science Translational Medicine
|
April 2, 2025
Ebola virus vaccination elicits Ebola virus-specific immune responses without substantial cross-reactivity to other filoviruses
Thembi Mdluli, Suzanne Wollen-Roberts, Mélanie Merbah, et al.
Vaccines
|
May 28, 2022
A SARS-CoV-2 Spike Ferritin Nanoparticle Vaccine Is Protective and Promotes a Strong Immunological Response in the Cynomolgus Macaque Coronavirus Disease 2019 (COVID-19) Model
Sara C Johnston, Keersten M Ricks, Ines Lakhal-Naouar, et al.
Page
of 10